# Sun Pharma is planning to refinance around $8 billion of Organon's debt, for which it plans to issue corporate guarantees.

*business · news · 2026-04-28 · Moneycontrol*

## Key points

- Sun Pharma will seek an RBI exemption from foreign remittance rules for the $11.75-billion Organon acquisition.
- Sun Pharma plans to refinance approximately $8 billion of Organon's debt with corporate guarantees to foreign lenders.
- ODI rules trigger RBI pre-approval for foreign guarantees or investments by Indian companies exceeding $1 billion.
- The acquisition uses a leveraged buyout structure where Organon's cash flows service the acquisition debt offshore.

**Companies:** Sun Pharma, Organon
**Countries:** India, United States

[Read the full story on Moneycontrol](https://www.moneycontrol.com/news/business/sun-pharma-to-approach-rbi-for-exemption-from-foreign-remittance-rules-13901888.html)

---

Canonical: https://newsio.io/n/cb0b3d34-5c13-48f2-8280-6b598218134f/sun-pharma-is-planning-to-refinance-around-8-billion-of-organons-debt-for-which
Summarized by Newsio from Moneycontrol. https://newsio.io/how-it-works